Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4

Journal of Investigative Dermatology

Volumn 108, Issue 4, 1997, Pages 406-411

  Asada, Hideo ^a   Linton, Jay ^a   Katz, Stephen I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

mRNA; T helper cells Th1 and Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTACT SENSITIVITY; CONTROLLED STUDY; GENE EXPRESSION; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030964049     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12289700     Document Type: Article

References (40)

1. Aoki I, Kinzer C, Shirai A, Paul WE, Klinman DM: IgE receptor-positive non-B/ non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice. Proc Natl Acad Sci USA 92:2534-2538, 1995
2. Berg DJ, Leach MW, Kühn R, Rajewsky K, Müller W, Davidson NJ, Rennick D: Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182:99-108, 1995
3. Uradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST: Interleukin 4 is localized to and released by human mast cells. J Exp Med 176:1381-1386, 1992
4. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE: B cell stimulatory factor-1/interlenkin-4 mRN A is expressed hy normal and transformed mast cells. Cell 50:809-818, 1987
5. Cher DJ, Mosmann TR: Two types of murinc helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 138:3688-3694, 1987
6. Coffman RL, Seymour BWP, Lebman DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski HM, Savelkoul HFJ, Finkelman FD, Bond MW, Mosmann TR: The role of helper T cell products in mouse B cell differentiation and isotype regulation, Immunol Rev 102:5-28, 1988
7. Fnk AH, Katz SI: Early molecular esents in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
8. Enk CD, Katz SI: Extraction and quantitation of cytokine mRNA from human epidermal blister roofs. Arch Dermatol Res 287:72-77, 1994
9. Erard F, Wild M-T, Garcia-Sanz JA, Gros GL: Switch of CD8 T cells to noncytolytic CD8- CD4- cells that make Th2 cytokines and help B cells. Scienice 260:1802-1805, 1993
10. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS: IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 142:3857-3861, 1989
11. Ferguson TA, Dube P, Griffith TS: Regulation of contact hypersensitivity by inter-leukin 10. J Exp Med 179:1597-1604, 1994
12. Fong TAT, Mosmann TR: The role of IFN-γ in delayed-type hypersensitiviry mediated by Tb1 clones. J Immunot 143:2887-2893, 1989
13. Gautam SC, Chikkala NF, Hamilton TA: Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene. J Immunol 148:1411-1415, 1992
14. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA: Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86:3803-3807, 1989
15. Hauser C: Cultured epidermal Langerhans cells activate effector T cells for contact sensitivity. J Invest Dermatol 95:436-440, 1990
16. Issekutz TB, Stoltz JM, Meide PVD: Lymphocyte recruitment in delayed-type hypersensirivity. The role of IFN-γ. J Immunol 140:2989-2993, 1988
17. v mice and their increase by bone marrow transplantation. Blood 52:447-452, 1978
18. Kondo S, McKenzie RC, Sauder DN: Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 103:811-814, 1994a
19. Kondo S, Pastore S, Shivji GM, McKenzie RC, Sauder DN: Characterization of epidermal cytokine profiles in sensirization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin. Lymphokine Cytokine Res 13:367-375, 1994b
20. Larsen CG, Ternowitz T, Larsen FG, Thestrup-Pedersen K: Epidermis and lymphocyte interactions during an allergic patch test reaction: increased activity of ETAF/ IL-1, epidermal derived lymphocyte chemotactic factor and mixed skin lymphocyte reactivity in persons with type IV allergy. J Invest Dermatol 90:230-233, 1988
21. Luger TA, Schwarz T: Evidence for an epidermal cytokine network. J Invest Dermatol 95(suppl):100s-104s, 1990
22. Martin S, Maruta K, Burkart V, Gillis S, Kolb H: IL-1 and IFN-γ increase vascular permeability. Immunology 64:301-305, 1988
23. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR: IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J Immunol 144:2211-2215, 1990
24. Mikhail GR, Miller-Milinska A: Mast cell population in human skin. J Invest Dermatol 43:249-254, 1964
25. Mohler KM, Butler LD: Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization. J Immunol 145:1734-1739, 1990
26. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
27. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL: Overexpression of IL-10 in atopic dermatitis. J Immunol 154:1956-1963, 1995
28. Paul WE: Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77:1859-1870, 1991
29. Peleman R, Wu J, Fargeas C, Delespesse G: Recombinant interleukin 4 suppresses the production of interferon y by human mononuclear cells. J Exp Med 170:1751-1756, 1989
30. Piguet PF, Grau GE, Hauser C, Vassalli P: Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679, 1991
31. Powrie F, Menon S, Coffman RL: Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 23:3043-3049, 1993
32. Salerno A, Dieli F, Sirecl G, Bellavia A, Asherson GL: Interleukin-4 is a critical cytokine in contact sensitivity. Immunology 84:404-409, 1995
33. Sauder DN, Dinarello CA, Morhenn VB: Langerhans cell production of interleukin-1. J Invest Dermatol 82:605-607, 1984
34. Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A, Schwarz T: In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 103:211-216, 1994
35. Seder RA, Boulay J-L, Finkelman F, Barbier S, Ben-Sasson SZ, Gros GL, Paul WE: CD8+ T cells can be primed in vitro to produce IL-4. J Immunol 148:1652-1656, 1992
36. Seder RA, Paul WE, Dvorak AM, Sharkis SJ, Kagey-Sobotka A, Niv Y, Finkelman FD, Barbieri SA, Galli SJ, Plaut M: Mouse splenic and bone marrow cell populations that express high-affinity Fc∈ receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci USA 88:2835-2839, 1991
37. Thomson JA, Troutt AB, Kelso A: Contact sensitization to oxazolone: involvement of both interferon-γ and interleukin-4 in oxazolone-specific Ig and T-cell responses. Immunology 78:185-192, 1993
38. Vercelli D, Jabara HH, Lauener RP, Geha RS: IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 144:570-573, 1990
39. + T cells. J Exp Med 183:1001-1012, 1996
40. + CD4- CD8- T cells produce IL-4. J Immunol 149:1211-1215, 1992